Kyverna Therapeutics, Inc. (KYTX) Free cash flow 2023–2025
Kyverna Therapeutics, Inc. (KYTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$153.7MFY2025 · since FY2023: -$53.0M → -$153.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$153.7M | -32.0% |
| FY2024 | -$116.5M | -119.6% |
| FY2023 | -$53.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice